A phase II trial of eltoprazine in aggressive elderly patients with Alzheimer's dementia

Trial Profile

A phase II trial of eltoprazine in aggressive elderly patients with Alzheimer's dementia

Completed
Phase of Trial: Phase II

Latest Information Update: 17 Apr 2017

At a glance

  • Drugs Eltoprazine (Primary)
  • Indications Alzheimer's disease; Dementia
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Apr 2017 Results published in an Amarantus Bioscience Holdings media release.
    • 11 Dec 2015 New trial record
    • 08 Dec 2015 Results published in an Amarantus Bioscience Holdings media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top